Twinlab Consolidated Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 14, 2023 at 04:31 pm EDT
Share
Twinlab Consolidated Holdings, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 4.88 million compared to USD 14.47 million a year ago. Net loss was USD 3.99 million compared to USD 2.22 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.
For the six months, sales was USD 13.9 million compared to USD 27.72 million a year ago. Net loss was USD 6.8 million compared to USD 1.94 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.
Twinlab Consolidated Holdings, Inc. is a marketer, distributor and direct-to-consumer retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty store retailers, on-line retailers, and websites. Internationally, the Company markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Through NutraScience Labs, it also provides services between private label distributors and contract manufacturers. Its services business involved the facilitation of manufacture of custom products. Its products include vitamins, minerals, resveratrol, collagen, keratin, skincare and sports nutrition products primarily under the Twinlab, Reserveage and ResVitale brands. It also markets and sells diet and energy products under the Metabolife brand and a full line of herbal teas under the Alvita brand.